Your browser doesn't support javascript.
loading
Design and discovery of a selective small molecule κ opioid antagonist (2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine, PF-4455242).
Verhoest, Patrick R; Basak, Aarti Sawant; Parikh, Vinod; Hayward, Matthew; Kauffman, Gregory W; Paradis, Vanessa; McHardy, Stanton F; McLean, Stafford; Grimwood, Sarah; Schmidt, Anne W; Vanase-Frawley, Michelle; Freeman, Jodi; Van Deusen, Jeffrey; Cox, Loretta; Wong, Diane; Liras, Spiros.
Affiliation
  • Verhoest PR; Neuroscience Medicinal Chemistry, Pfizer PharmaTherapeutics Research and Development, Groton, Connecticut, USA. patrick.r.verhoest@pfizer.com
J Med Chem ; 54(16): 5868-77, 2011 Aug 25.
Article in En | MEDLINE | ID: mdl-21744827

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Biphenyl Compounds / Drug Design / Receptors, Opioid, kappa / Drug Discovery / Narcotic Antagonists Type of study: Prognostic_studies Language: En Year: 2011 Type: Article

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Biphenyl Compounds / Drug Design / Receptors, Opioid, kappa / Drug Discovery / Narcotic Antagonists Type of study: Prognostic_studies Language: En Year: 2011 Type: Article